Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 79 citing Targher: Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular.... (0.08 sec) 

Fatty liver: a novel component of the metabolic syndrome

- ahajournals.org
A Kotronen, H Yki-Jarvinen - Arteriosclerosis, Thrombosis, and Vascular Biology, 2008 - Am Heart Assoc
Although the epidemic of obesity has been accompanied by an increase in the
prevalence of the metabolic syndrome, not all obese develop the syndrome and
even lean individuals can be insulin resistant. Both lean and obese insulin ...
Cited by 77 - Related articles - All 6 versions

Identification and characterization of metabolically benign obesity in humans


N Stefan, K Kantartzis, J Machann, F Schick, C … - Archives of Internal Medicine, 2008 - Am Med Assoc
Methods In 314 subjects, we measured total body, visceral, and subcutaneous fat
with magnetic resonance (MR) tomography and fat in the liver and skeletal muscle
with proton MR spectroscopy. Insulin sensitivity was estimated from oral ...
Cited by 50 - Related articles - All 5 versions

Non-alcoholic fatty liver disease: the mist gradually clears

- ucsf.edu [PDF] 
NMW de Alwis, CP Day - Journal of Hepatology, 2008 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver disorder in
the developed world affecting up to a third of individuals. It is closely
associated with features of the metabolic syndrome, particularly obesity ...
Cited by 45 - Related articles - All 35 versions

Nonalcoholic fatty liver disease is independently associated with an increased incidence of …

- Free from Publisher
G Targher, L Bertolini, S Rodella, R Tessari, L … - Diabetes Care, 2007 - Am Diabetes Assoc
Recent data suggest that the presence of nonalcoholic fatty liver disease
(NAFLD) in type 2 diabetes may be linked to increased cardiovascular disease
(CVD) independent of components of the metabolic syndrome (1–3), although ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine …

- diabetesjournals.org
A Kotronen, L Juurinen, A Hakkarainen, J … - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—The type 2 diabetic patients had, on average, 80% more liver fat and
16% more intra-abdominal fat than the nondiabetic subjects. The difference in
liver fat between the two groups remained statistically significant when ...
Cited by 18 - Related articles - BL Direct - All 7 versions

Genes and nonalcoholic fatty liver disease


NMW de Alwis, CP Day - Current Diabetes Reports, 2008 - Springer
Whereas most individuals with nonalcoholic fatty liver disease (NAFLD) will have
steatosis, only a minority will ever develop progressive disease. Family studies
and interethnic variations in susceptibility suggest that genetic factors ...
Cited by 16 - Related articles - BL Direct

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and …


W Goessling, JM Massaro, RS Vasan, RB D' … - Gastroenterology, 2008 - Elsevier
Among individuals at baseline, per 1 standard deviation increase in log ALT
level, there were increased odds of the development of MetS (odds ratio [OR]
1.21, P < .001) and diabetes (OR, 1.48; P < .0001) over 20 years of ...
Cited by 15 - Related articles - All 2 versions

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect …

- geyseco.info [PDF] 
G Targher, F Marra, G Marchesini - Diabetologia, 2008 - Springer
Abstract Non-alcoholic fatty liver disease (NAFLD), comprising a spectrum of
conditions ranging from pure steatosis to steatohepatitis and cirrhosis, has
reached epidemic proportions and represents the most common cause of ...
Cited by 14 - Related articles - All 3 versions

Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis


G Targher, L Bertolini, L Scala, L Zenari, G … - Diabetes Care, 2007 - Am Diabetes Assoc
Recent data suggest that nonalcoholic fatty liver disease (NAFLD) is linked to
increased cardiovascular disease (CVD) risk independently of the metabolic
syndrome (MetS) (1–7), although the possible molecular mediators linking ...
Cited by 12 - Related articles - All 4 versions

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

- aspetjournals.org
N Anderson, J Borlak - Pharmacological reviews, 2008 - ASPET
Cited by 14 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google